Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.40980110 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58145500 |
3 | negative regulation of cell killing (GO:0031342) | 5.58145500 |
4 | negative T cell selection (GO:0043383) | 5.46662065 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.36755881 |
6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.13516207 |
7 | negative thymic T cell selection (GO:0045060) | 5.12202072 |
8 | leukocyte aggregation (GO:0070486) | 5.06681076 |
9 | positive thymic T cell selection (GO:0045059) | 5.02479546 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.00226908 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.99265659 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97297029 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.97297029 |
14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.85386433 |
15 | positive T cell selection (GO:0043368) | 4.80699517 |
16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.68667309 |
17 | interferon-gamma production (GO:0032609) | 4.65414252 |
18 | tolerance induction (GO:0002507) | 4.57202677 |
19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.53332520 |
20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.52528802 |
21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.41416787 |
22 | response to interleukin-15 (GO:0070672) | 4.37203394 |
23 | T cell selection (GO:0045058) | 4.36058234 |
24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.29048911 |
25 | thymic T cell selection (GO:0045061) | 4.24625283 |
26 | cellular response to interleukin-15 (GO:0071350) | 4.16547349 |
27 | detection of other organism (GO:0098543) | 4.14010953 |
28 | activated T cell proliferation (GO:0050798) | 4.13141105 |
29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.01232889 |
30 | neutrophil activation (GO:0042119) | 4.00086815 |
31 | regulation of B cell differentiation (GO:0045577) | 3.97133200 |
32 | T cell migration (GO:0072678) | 3.95565449 |
33 | detection of bacterium (GO:0016045) | 3.89097186 |
34 | mast cell activation (GO:0045576) | 3.85812765 |
35 | granulocyte activation (GO:0036230) | 3.84181595 |
36 | macrophage activation involved in immune response (GO:0002281) | 3.83219298 |
37 | positive regulation of B cell differentiation (GO:0045579) | 3.82404760 |
38 | response to peptidoglycan (GO:0032494) | 3.79413686 |
39 | B cell receptor signaling pathway (GO:0050853) | 3.78670389 |
40 | regulation of regulatory T cell differentiation (GO:0045589) | 3.76667041 |
41 | T cell costimulation (GO:0031295) | 3.73556858 |
42 | positive regulation of isotype switching (GO:0045830) | 3.72270533 |
43 | lymphocyte costimulation (GO:0031294) | 3.70649234 |
44 | T cell receptor signaling pathway (GO:0050852) | 3.66973681 |
45 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.63882547 |
46 | detection of external biotic stimulus (GO:0098581) | 3.61960941 |
47 | detection of molecule of bacterial origin (GO:0032490) | 3.60229482 |
48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.59918025 |
49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58481317 |
50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.56364489 |
51 | regulation of tolerance induction (GO:0002643) | 3.55812117 |
52 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.53444251 |
53 | myeloid dendritic cell activation (GO:0001773) | 3.53126525 |
54 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.45828487 |
55 | positive regulation of B cell mediated immunity (GO:0002714) | 3.45828487 |
56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39704995 |
57 | dendritic cell chemotaxis (GO:0002407) | 3.39329289 |
58 | myeloid cell activation involved in immune response (GO:0002275) | 3.36285106 |
59 | microglial cell activation (GO:0001774) | 3.36178058 |
60 | negative regulation of interleukin-12 production (GO:0032695) | 3.33209266 |
61 | positive regulation of interleukin-2 production (GO:0032743) | 3.32861955 |
62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.32729291 |
63 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31461349 |
64 | positive regulation of tolerance induction (GO:0002645) | 3.30358942 |
65 | T cell homeostasis (GO:0043029) | 3.28343506 |
66 | regulation of isotype switching (GO:0045191) | 3.28262728 |
67 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.28117154 |
68 | detection of biotic stimulus (GO:0009595) | 3.27299340 |
69 | leukocyte cell-cell adhesion (GO:0007159) | 3.26448671 |
70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.24819082 |
71 | dendritic cell migration (GO:0036336) | 3.24149619 |
72 | regulation of B cell mediated immunity (GO:0002712) | 3.24136231 |
73 | regulation of T cell tolerance induction (GO:0002664) | 3.22715001 |
74 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.22561115 |
75 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.22552548 |
76 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.22552548 |
77 | negative regulation of B cell proliferation (GO:0030889) | 3.21322827 |
78 | response to host immune response (GO:0052572) | 3.21087724 |
79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21087724 |
80 | positive regulation of DNA recombination (GO:0045911) | 3.20285741 |
81 | myeloid dendritic cell differentiation (GO:0043011) | 3.19476297 |
82 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19331609 |
83 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.18734175 |
84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.18397068 |
85 | cytidine deamination (GO:0009972) | 3.15246849 |
86 | cytidine metabolic process (GO:0046087) | 3.15246849 |
87 | cytidine catabolic process (GO:0006216) | 3.15246849 |
88 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.14345184 |
89 | leukocyte degranulation (GO:0043299) | 3.13735526 |
90 | macrophage activation (GO:0042116) | 3.12952471 |
91 | immunoglobulin mediated immune response (GO:0016064) | 3.12512806 |
92 | neutrophil mediated immunity (GO:0002446) | 3.11636981 |
93 | type I interferon signaling pathway (GO:0060337) | 3.11385863 |
94 | cellular response to type I interferon (GO:0071357) | 3.11385863 |
95 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.11193332 |
96 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.11193332 |
97 | T cell proliferation (GO:0042098) | 3.08646380 |
98 | response to type I interferon (GO:0034340) | 3.08274060 |
99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.06377315 |
100 | lymphocyte homeostasis (GO:0002260) | 3.03657893 |
101 | positive regulation of immunoglobulin production (GO:0002639) | 3.02877501 |
102 | alpha-beta T cell activation (GO:0046631) | 3.02572435 |
103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.01732752 |
104 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.01545700 |
105 | regulation of mast cell degranulation (GO:0043304) | 3.01371212 |
106 | positive regulation of mast cell activation (GO:0033005) | 3.00504571 |
107 | negative regulation of phagocytosis (GO:0050765) | 2.99523673 |
108 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.99383101 |
109 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99274206 |
110 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.98569915 |
111 | regulation of cell killing (GO:0031341) | 2.97576175 |
112 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97477615 |
113 | defense response to protozoan (GO:0042832) | 2.97117069 |
114 | response to protozoan (GO:0001562) | 2.96565244 |
115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96427771 |
116 | regulation of response to interferon-gamma (GO:0060330) | 2.95637121 |
117 | B cell mediated immunity (GO:0019724) | 2.95521697 |
118 | neutrophil activation involved in immune response (GO:0002283) | 2.95475855 |
119 | regulation of immunoglobulin production (GO:0002637) | 2.95469277 |
120 | T cell differentiation (GO:0030217) | 2.95389135 |
121 | regulation of mast cell activation (GO:0033003) | 2.95027830 |
122 | NIK/NF-kappaB signaling (GO:0038061) | 2.92719224 |
123 | myeloid leukocyte activation (GO:0002274) | 2.92572986 |
124 | negative regulation of adaptive immune response (GO:0002820) | 2.92562233 |
125 | regulation of B cell proliferation (GO:0030888) | 2.92295492 |
126 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.90904905 |
127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.89217715 |
128 | regulation of chronic inflammatory response (GO:0002676) | 2.89185281 |
129 | alpha-beta T cell differentiation (GO:0046632) | 2.87889275 |
130 | cellular extravasation (GO:0045123) | 2.87832240 |
131 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87477002 |
132 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87073696 |
133 | respiratory burst (GO:0045730) | 2.86842336 |
134 | positive regulation of humoral immune response (GO:0002922) | 2.85779995 |
135 | positive regulation of cell killing (GO:0031343) | 2.85315608 |
136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.85163739 |
137 | mature B cell differentiation (GO:0002335) | 2.84948908 |
138 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.83186752 |
139 | modulation by symbiont of host immune response (GO:0052553) | 2.83186752 |
140 | positive regulation by symbiont of host defense response (GO:0052509) | 2.83186752 |
141 | modulation by symbiont of host defense response (GO:0052031) | 2.83186752 |
142 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.83186752 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.52217389 |
2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.36739866 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40367928 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80386347 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72571263 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.72479042 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.66103449 |
8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64310619 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52932969 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.44191465 |
11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11530116 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 3.10144589 |
13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.07607877 |
14 | * MYB_26560356_Chip-Seq_TH2_Human | 3.01220853 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00186719 |
16 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.95890767 |
17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89684385 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87761542 |
19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83999619 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.69303431 |
21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.69130062 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62612677 |
23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.57116255 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50790742 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49673123 |
26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.43217077 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39808739 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.32891202 |
29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32797458 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.28332529 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12499662 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07213916 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06995164 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02901052 |
35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.01048719 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94571776 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90470140 |
38 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.89132947 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84334806 |
40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83049484 |
41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81631281 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75712607 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70411159 |
44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63232990 |
45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.61985926 |
46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61220252 |
47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.60740502 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58762852 |
49 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.54741303 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53160748 |
51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51864029 |
52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47677531 |
53 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44088160 |
54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40471802 |
55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35286635 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31164160 |
57 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29820005 |
58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28228204 |
59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25870639 |
60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25111929 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24943135 |
62 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24363229 |
63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24235454 |
64 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20204768 |
65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19826113 |
66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19242909 |
67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17589032 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17264056 |
69 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13053352 |
70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12976653 |
71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12594657 |
72 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.11458293 |
73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09527810 |
74 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08569854 |
75 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08238644 |
76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08071377 |
77 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05047875 |
78 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03928884 |
79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01085085 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99883685 |
81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97231953 |
82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97135280 |
83 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96891416 |
84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96619926 |
85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95871106 |
86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92409354 |
87 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91239695 |
88 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91071659 |
89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90092914 |
90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89818463 |
91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87998743 |
92 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86707420 |
93 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.85608018 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82626275 |
95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81312946 |
96 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80359851 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78700064 |
98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77508671 |
99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77324177 |
100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76637999 |
101 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75933602 |
102 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73329384 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72949242 |
104 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72521220 |
105 | GATA3_26560356_Chip-Seq_TH1_Human | 0.72465857 |
106 | GATA1_22025678_ChIP-Seq_K562_Human | 0.71885242 |
107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71629774 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71460204 |
109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.70857991 |
110 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69988315 |
111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69419588 |
112 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.68787627 |
113 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68478387 |
114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67994658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.33134403 |
2 | MP0005671_abnormal_response_to | 4.19743415 |
3 | MP0003763_abnormal_thymus_physiology | 3.66274782 |
4 | MP0001800_abnormal_humoral_immune | 3.20833254 |
5 | MP0000685_abnormal_immune_system | 3.20781167 |
6 | MP0003303_peritoneal_inflammation | 3.15296295 |
7 | MP0009785_altered_susceptibility_to | 3.11480816 |
8 | MP0001790_abnormal_immune_system | 3.08144613 |
9 | MP0005387_immune_system_phenotype | 3.08144613 |
10 | MP0005000_abnormal_immune_tolerance | 3.04026329 |
11 | MP0003436_decreased_susceptibility_to | 3.02324319 |
12 | MP0002723_abnormal_immune_serum | 2.78860164 |
13 | MP0002452_abnormal_antigen_presenting | 2.77776756 |
14 | MP0002420_abnormal_adaptive_immunity | 2.76957996 |
15 | MP0001819_abnormal_immune_cell | 2.74266604 |
16 | MP0005025_abnormal_response_to | 2.65691558 |
17 | MP0002166_altered_tumor_susceptibility | 2.65521609 |
18 | MP0003300_gastrointestinal_ulcer | 2.64519198 |
19 | * MP0002398_abnormal_bone_marrow | 2.55310673 |
20 | MP0002419_abnormal_innate_immunity | 2.51038031 |
21 | MP0002405_respiratory_system_inflammati | 2.49974197 |
22 | MP0002148_abnormal_hypersensitivity_rea | 2.48201310 |
23 | MP0006082_CNS_inflammation | 2.35950365 |
24 | MP0009333_abnormal_splenocyte_physiolog | 2.33362158 |
25 | MP0003724_increased_susceptibility_to | 2.33079529 |
26 | MP0002396_abnormal_hematopoietic_system | 2.32376370 |
27 | * MP0000716_abnormal_immune_system | 2.29679830 |
28 | MP0001873_stomach_inflammation | 2.24392150 |
29 | MP0002006_tumorigenesis | 2.21043693 |
30 | MP0010155_abnormal_intestine_physiology | 2.15145929 |
31 | MP0005464_abnormal_platelet_physiology | 2.14573277 |
32 | MP0001853_heart_inflammation | 2.14367269 |
33 | MP0000689_abnormal_spleen_morphology | 2.11679012 |
34 | MP0002722_abnormal_immune_system | 2.11040298 |
35 | MP0000703_abnormal_thymus_morphology | 2.08755695 |
36 | MP0000465_gastrointestinal_hemorrhage | 2.01387009 |
37 | MP0004947_skin_inflammation | 1.92383374 |
38 | * MP0002429_abnormal_blood_cell | 1.90403135 |
39 | MP0001845_abnormal_inflammatory_respons | 1.86976552 |
40 | MP0004510_myositis | 1.85852178 |
41 | MP0004808_abnormal_hematopoietic_stem | 1.77795967 |
42 | MP0003866_abnormal_defecation | 1.72620856 |
43 | MP0002933_joint_inflammation | 1.63836611 |
44 | MP0008260_abnormal_autophagy | 1.52434559 |
45 | MP0004381_abnormal_hair_follicle | 1.49655620 |
46 | MP0001533_abnormal_skeleton_physiology | 1.46868183 |
47 | MP0001545_abnormal_hematopoietic_system | 1.43117144 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.43117144 |
49 | MP0000858_altered_metastatic_potential | 1.35049345 |
50 | MP0000490_abnormal_crypts_of | 1.31527189 |
51 | MP0008469_abnormal_protein_level | 1.26213271 |
52 | MP0009278_abnormal_bone_marrow | 1.23016359 |
53 | MP0005310_abnormal_salivary_gland | 1.21986923 |
54 | MP0003448_altered_tumor_morphology | 1.21508631 |
55 | MP0005174_abnormal_tail_pigmentation | 1.11551680 |
56 | MP0001851_eye_inflammation | 1.06442314 |
57 | MP0002132_abnormal_respiratory_system | 1.05962097 |
58 | MP0002998_abnormal_bone_remodeling | 1.02384134 |
59 | MP0008057_abnormal_DNA_replication | 1.02208804 |
60 | MP0004883_abnormal_blood_vessel | 0.98882303 |
61 | MP0003656_abnormal_erythrocyte_physiolo | 0.98508864 |
62 | MP0000343_altered_response_to | 0.98343287 |
63 | MP0003172_abnormal_lysosome_physiology | 0.98328130 |
64 | MP0003183_abnormal_peptide_metabolism | 0.98101553 |
65 | MP0003191_abnormal_cellular_cholesterol | 0.96474165 |
66 | MP0002019_abnormal_tumor_incidence | 0.94057200 |
67 | MP0009764_decreased_sensitivity_to | 0.91744809 |
68 | MP0005451_abnormal_body_composition | 0.90733670 |
69 | MP0005058_abnormal_lysosome_morphology | 0.87994032 |
70 | MP0005075_abnormal_melanosome_morpholog | 0.85388388 |
71 | MP0003690_abnormal_glial_cell | 0.83015681 |
72 | MP0003075_altered_response_to | 0.82190856 |
73 | MP0005076_abnormal_cell_differentiation | 0.82116930 |
74 | MP0005164_abnormal_response_to | 0.80036852 |
75 | MP0005166_decreased_susceptibility_to | 0.78792161 |
76 | MP0001663_abnormal_digestive_system | 0.77970030 |
77 | MP0010307_abnormal_tumor_latency | 0.77183659 |
78 | MP0010352_gastrointestinal_tract_polyps | 0.73920638 |
79 | MP0010094_abnormal_chromosome_stability | 0.71296741 |
80 | MP0001986_abnormal_taste_sensitivity | 0.71048136 |
81 | MP0009763_increased_sensitivity_to | 0.70909462 |
82 | MP0003693_abnormal_embryo_hatching | 0.70119530 |
83 | MP0000249_abnormal_blood_vessel | 0.69682914 |
84 | MP0000015_abnormal_ear_pigmentation | 0.69588277 |
85 | MP0004782_abnormal_surfactant_physiolog | 0.69196789 |
86 | MP0008007_abnormal_cellular_replicative | 0.69074180 |
87 | MP0008961_abnormal_basal_metabolism | 0.68140653 |
88 | MP0003795_abnormal_bone_structure | 0.67268990 |
89 | MP0002095_abnormal_skin_pigmentation | 0.66992338 |
90 | MP0002009_preneoplasia | 0.66884383 |
91 | MP0000604_amyloidosis | 0.65019087 |
92 | MP0003077_abnormal_cell_cycle | 0.64264136 |
93 | MP0008004_abnormal_stomach_pH | 0.60791608 |
94 | MP0000920_abnormal_myelination | 0.59451822 |
95 | MP0006054_spinal_hemorrhage | 0.59415107 |
96 | MP0005390_skeleton_phenotype | 0.55718833 |
97 | MP0008874_decreased_physiological_sensi | 0.55418754 |
98 | MP0003806_abnormal_nucleotide_metabolis | 0.55334754 |
99 | MP0004130_abnormal_muscle_cell | 0.53457794 |
100 | MP0008873_increased_physiological_sensi | 0.53247881 |
101 | MP0000569_abnormal_digit_pigmentation | 0.53004746 |
102 | MP0005023_abnormal_wound_healing | 0.52652628 |
103 | MP0002136_abnormal_kidney_physiology | 0.52565961 |
104 | MP0003828_pulmonary_edema | 0.52377058 |
105 | MP0000477_abnormal_intestine_morphology | 0.51757510 |
106 | MP0000609_abnormal_liver_physiology | 0.50550368 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.50220993 |
108 | MP0000313_abnormal_cell_death | 0.49581790 |
109 | MP0002693_abnormal_pancreas_physiology | 0.49321574 |
110 | MP0008058_abnormal_DNA_repair | 0.48947438 |
111 | MP0003045_fibrosis | 0.48122054 |
112 | MP0009840_abnormal_foam_cell | 0.46616186 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.46614346 |
114 | MP0002138_abnormal_hepatobiliary_system | 0.46442324 |
115 | MP0005319_abnormal_enzyme/_coenzyme | 0.44445187 |
116 | MP0003787_abnormal_imprinting | 0.42811773 |
117 | MP0005388_respiratory_system_phenotype | 0.42324055 |
118 | MP0002133_abnormal_respiratory_system | 0.42324055 |
119 | MP0001191_abnormal_skin_condition | 0.41194770 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 5.34028410 |
2 | Myositis (HP:0100614) | 5.28846367 |
3 | Abnormality of T cell number (HP:0011839) | 5.11249041 |
4 | Eczematoid dermatitis (HP:0000976) | 5.04327056 |
5 | Optic neuritis (HP:0100653) | 4.85540843 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.85540843 |
7 | IgM deficiency (HP:0002850) | 4.79749283 |
8 | Recurrent abscess formation (HP:0002722) | 4.77164520 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.69530288 |
10 | Orchitis (HP:0100796) | 4.61506081 |
11 | Recurrent viral infections (HP:0004429) | 4.57541748 |
12 | B lymphocytopenia (HP:0010976) | 4.52430260 |
13 | Abnormality of B cell number (HP:0010975) | 4.52430260 |
14 | Recurrent fungal infections (HP:0002841) | 4.48883601 |
15 | Recurrent bacterial skin infections (HP:0005406) | 4.24906365 |
16 | Panhypogammaglobulinemia (HP:0003139) | 4.24089743 |
17 | Abnormality of T cells (HP:0002843) | 4.19313710 |
18 | Severe combined immunodeficiency (HP:0004430) | 4.13500533 |
19 | Stomatitis (HP:0010280) | 4.03044402 |
20 | Meningitis (HP:0001287) | 3.92284105 |
21 | Thyroiditis (HP:0100646) | 3.89215203 |
22 | Combined immunodeficiency (HP:0005387) | 3.87627709 |
23 | Recurrent bronchitis (HP:0002837) | 3.86635413 |
24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.63741556 |
25 | Obstructive lung disease (HP:0006536) | 3.63741556 |
26 | Vasculitis (HP:0002633) | 3.62601511 |
27 | Pulmonary infiltrates (HP:0002113) | 3.53057479 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 3.52767597 |
29 | IgG deficiency (HP:0004315) | 3.49005253 |
30 | Keratoconjunctivitis sicca (HP:0001097) | 3.39888075 |
31 | Arterial thrombosis (HP:0004420) | 3.32314946 |
32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28524820 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28524820 |
34 | Chronic otitis media (HP:0000389) | 3.27477381 |
35 | Eosinophilia (HP:0001880) | 3.24949354 |
36 | Recurrent skin infections (HP:0001581) | 3.19236978 |
37 | Leukocytosis (HP:0001974) | 3.16104261 |
38 | Hemoptysis (HP:0002105) | 3.14417434 |
39 | Abnormality of eosinophils (HP:0001879) | 3.14393343 |
40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.14356210 |
41 | Abnormality of T cell physiology (HP:0011840) | 3.11151249 |
42 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.06650238 |
43 | Keratoconjunctivitis (HP:0001096) | 3.06495114 |
44 | Lymphopenia (HP:0001888) | 3.05025389 |
45 | Thrombocytosis (HP:0001894) | 3.04734222 |
46 | Nasal polyposis (HP:0100582) | 2.96724910 |
47 | Urticaria (HP:0001025) | 2.93556965 |
48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.92937205 |
49 | Agammaglobulinemia (HP:0004432) | 2.92865149 |
50 | Inflammation of the large intestine (HP:0002037) | 2.89417155 |
51 | Encephalitis (HP:0002383) | 2.88106401 |
52 | Pustule (HP:0200039) | 2.85411647 |
53 | Granulocytopenia (HP:0001913) | 2.85143490 |
54 | Cellulitis (HP:0100658) | 2.83644680 |
55 | Chronic diarrhea (HP:0002028) | 2.80972696 |
56 | Spontaneous hematomas (HP:0007420) | 2.80147381 |
57 | Gastrointestinal inflammation (HP:0004386) | 2.78394896 |
58 | Abnormality of the prostate (HP:0008775) | 2.75711697 |
59 | Petechiae (HP:0000967) | 2.72106269 |
60 | Chest pain (HP:0100749) | 2.71579777 |
61 | Abnormality of the fingertips (HP:0001211) | 2.71010998 |
62 | Autoimmune thrombocytopenia (HP:0001973) | 2.70509712 |
63 | Abnormality of macrophages (HP:0004311) | 2.69595981 |
64 | Hypoplasia of the thymus (HP:0000778) | 2.68069910 |
65 | Gastrointestinal stroma tumor (HP:0100723) | 2.68020158 |
66 | IgA deficiency (HP:0002720) | 2.67126718 |
67 | Recurrent sinusitis (HP:0011108) | 2.63444519 |
68 | Epistaxis (HP:0000421) | 2.61155329 |
69 | Hypochromic anemia (HP:0001931) | 2.60563537 |
70 | Pulmonary embolism (HP:0002204) | 2.59310518 |
71 | Hypochromic microcytic anemia (HP:0004840) | 2.59231560 |
72 | Colitis (HP:0002583) | 2.59205808 |
73 | Abnormality of the nasal mucosa (HP:0000433) | 2.59197225 |
74 | Gastrointestinal infarctions (HP:0005244) | 2.54455560 |
75 | Increased density of long bones (HP:0006392) | 2.52037455 |
76 | Gingivitis (HP:0000230) | 2.49113683 |
77 | Lymphoma (HP:0002665) | 2.46928576 |
78 | Prolonged bleeding time (HP:0003010) | 2.45191449 |
79 | Episodic fever (HP:0001954) | 2.44799105 |
80 | Periodontitis (HP:0000704) | 2.42566358 |
81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.41543849 |
82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.41543849 |
83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.41543849 |
84 | Gangrene (HP:0100758) | 2.41414280 |
85 | Gingival bleeding (HP:0000225) | 2.34999653 |
86 | Increased cerebral lipofuscin (HP:0011813) | 2.32402315 |
87 | Osteomyelitis (HP:0002754) | 2.26940718 |
88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25786745 |
89 | Abnormality of the pleura (HP:0002103) | 2.23534471 |
90 | Interstitial pulmonary disease (HP:0006530) | 2.21807754 |
91 | Verrucae (HP:0200043) | 2.21581402 |
92 | Papilloma (HP:0012740) | 2.21581402 |
93 | Premature loss of primary teeth (HP:0006323) | 2.20674140 |
94 | Joint swelling (HP:0001386) | 2.19031941 |
95 | Increased IgM level (HP:0003496) | 2.15377156 |
96 | Autoimmune hemolytic anemia (HP:0001890) | 2.12913114 |
97 | Bronchitis (HP:0012387) | 2.07197853 |
98 | Abnormal platelet volume (HP:0011876) | 2.07190845 |
99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06617155 |
100 | Vertigo (HP:0002321) | 2.05530559 |
101 | Glomerulopathy (HP:0100820) | 2.05240349 |
102 | Restrictive lung disease (HP:0002091) | 2.05044250 |
103 | Hypergammaglobulinemia (HP:0010702) | 2.05005007 |
104 | Purpura (HP:0000979) | 2.04503445 |
105 | Increased IgE level (HP:0003212) | 2.03884564 |
106 | Abnormal platelet function (HP:0011869) | 2.02195294 |
107 | Impaired platelet aggregation (HP:0003540) | 2.02195294 |
108 | Keratitis (HP:0000491) | 2.01759069 |
109 | Abnormality of the pericardium (HP:0001697) | 1.99511694 |
110 | Sepsis (HP:0100806) | 1.98814294 |
111 | Fatigue (HP:0012378) | 1.98497852 |
112 | Polyneuropathy (HP:0001271) | 1.98223789 |
113 | Recurrent pneumonia (HP:0006532) | 1.97021463 |
114 | Arthralgia (HP:0002829) | 1.96850685 |
115 | Stomach cancer (HP:0012126) | 1.94689789 |
116 | Hepatosplenomegaly (HP:0001433) | 1.94507240 |
117 | Abnormality of the endocardium (HP:0004306) | 1.92835946 |
118 | Anorexia (HP:0002039) | 1.92779009 |
119 | Acute hepatic failure (HP:0006554) | 1.92051240 |
120 | Skin rash (HP:0000988) | 1.90836882 |
121 | Slow saccadic eye movements (HP:0000514) | 1.89959451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.59907621 |
2 | MAP4K1 | 5.68540983 |
3 | ZAP70 | 2.98050552 |
4 | ITK | 2.72795849 |
5 | JAK3 | 2.62259804 |
6 | MAP3K14 | 2.51347805 |
7 | TYK2 | 2.32699936 |
8 | STK10 | 2.20288185 |
9 | TEC | 2.18142312 |
10 | BTK | 2.07506240 |
11 | BLK | 2.06845224 |
12 | IRAK4 | 2.06449403 |
13 | IKBKE | 2.04854863 |
14 | SYK | 2.01884893 |
15 | JAK1 | 1.92949866 |
16 | TBK1 | 1.88195542 |
17 | GRK6 | 1.83613362 |
18 | KIT | 1.82889719 |
19 | TAOK3 | 1.72769930 |
20 | CSK | 1.72221319 |
21 | LCK | 1.68558970 |
22 | HCK | 1.66775867 |
23 | FGR | 1.58598406 |
24 | RIPK4 | 1.56695781 |
25 | PRPF4B | 1.54121913 |
26 | IRAK3 | 1.53741347 |
27 | IKBKB | 1.50267054 |
28 | CSF1R | 1.43612064 |
29 | FGFR4 | 1.42492583 |
30 | FGFR3 | 1.41300512 |
31 | TGFBR2 | 1.40079700 |
32 | EEF2K | 1.35712629 |
33 | FES | 1.34311480 |
34 | MAP3K13 | 1.28724717 |
35 | CLK1 | 1.25398003 |
36 | IRAK1 | 1.24819051 |
37 | PIM1 | 1.24392249 |
38 | LYN | 1.17933784 |
39 | CAMKK2 | 1.15159239 |
40 | MAP2K3 | 1.12795812 |
41 | MAP3K3 | 1.06751563 |
42 | IRAK2 | 1.06489816 |
43 | CHUK | 1.00404586 |
44 | JAK2 | 1.00230292 |
45 | PIK3CG | 0.97476378 |
46 | ERN1 | 0.95685068 |
47 | LRRK2 | 0.95387487 |
48 | SIK2 | 0.93296891 |
49 | BMPR2 | 0.92134068 |
50 | RPS6KA4 | 0.90655047 |
51 | PRKCQ | 0.90144788 |
52 | EPHB1 | 0.87609806 |
53 | MAP3K10 | 0.87034847 |
54 | GRK7 | 0.84793840 |
55 | MAP3K1 | 0.84429789 |
56 | PKN2 | 0.83264064 |
57 | MARK3 | 0.79575867 |
58 | NLK | 0.76294682 |
59 | MST4 | 0.74290429 |
60 | MAP3K6 | 0.73095687 |
61 | FLT3 | 0.68473730 |
62 | TESK2 | 0.67011651 |
63 | TSSK6 | 0.65604596 |
64 | PDK1 | 0.64058301 |
65 | NME2 | 0.58504123 |
66 | TNK2 | 0.58436916 |
67 | MAP3K12 | 0.57733287 |
68 | KDR | 0.57599465 |
69 | ACVR1B | 0.57419170 |
70 | STK4 | 0.57220385 |
71 | CDK4 | 0.56674623 |
72 | TAOK2 | 0.56207631 |
73 | MAP3K7 | 0.55593695 |
74 | BCKDK | 0.55496175 |
75 | KSR2 | 0.55060888 |
76 | SIK3 | 0.54847966 |
77 | TRIB3 | 0.54577249 |
78 | MARK2 | 0.53870752 |
79 | CDC42BPA | 0.51396030 |
80 | CDK6 | 0.51104692 |
81 | CDK12 | 0.50122499 |
82 | PRKCH | 0.49600326 |
83 | MAPK4 | 0.49163376 |
84 | MAP3K5 | 0.47841345 |
85 | PDGFRB | 0.47560796 |
86 | CAMKK1 | 0.46445705 |
87 | TAOK1 | 0.46342454 |
88 | MAP2K2 | 0.44319818 |
89 | NEK9 | 0.44168090 |
90 | PDPK1 | 0.42843209 |
91 | FYN | 0.42474312 |
92 | ALK | 0.42432927 |
93 | MATK | 0.42358242 |
94 | STK24 | 0.42171020 |
95 | PRKD2 | 0.40355216 |
96 | STK11 | 0.40333700 |
97 | PTK2B | 0.39742479 |
98 | DAPK2 | 0.38391496 |
99 | MAPK12 | 0.38026895 |
100 | TYRO3 | 0.37798302 |
101 | MAPK7 | 0.37065317 |
102 | SGK3 | 0.36391139 |
103 | SGK2 | 0.35263419 |
104 | HIPK2 | 0.34737736 |
105 | MAPKAPK2 | 0.34655936 |
106 | MAP3K8 | 0.34463361 |
107 | ABL1 | 0.33443177 |
108 | EPHA3 | 0.32048946 |
109 | MAP3K2 | 0.32014091 |
110 | EGFR | 0.31969736 |
111 | MAP2K6 | 0.31851396 |
112 | RPS6KA6 | 0.31629817 |
113 | CDK9 | 0.31560063 |
114 | CAMK4 | 0.31556161 |
115 | MAP3K11 | 0.30931110 |
116 | MELK | 0.30477791 |
117 | IGF1R | 0.30420377 |
118 | CDK19 | 0.29851516 |
119 | PIM2 | 0.29742261 |
120 | RET | 0.29303644 |
121 | MAPK11 | 0.27610725 |
122 | FRK | 0.26092718 |
123 | NEK2 | 0.26049053 |
124 | TGFBR1 | 0.25849025 |
125 | ADRBK2 | 0.25310419 |
126 | YES1 | 0.25255085 |
127 | PTK6 | 0.24239256 |
128 | INSR | 0.24038140 |
129 | MAPK3 | 0.22892128 |
130 | RAF1 | 0.22111322 |
131 | PRKCD | 0.21883019 |
132 | RPS6KC1 | 0.20577719 |
133 | RPS6KL1 | 0.20577719 |
134 | TRPM7 | 0.19818496 |
135 | DMPK | 0.19727581 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.22725309 |
2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.23281148 |
3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.99240232 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.84973596 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.79101974 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75346712 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.56663130 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.51025686 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.50536486 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43063552 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39809363 |
12 | Measles_Homo sapiens_hsa05162 | 2.35763889 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34794579 |
14 | Asthma_Homo sapiens_hsa05310 | 2.31954676 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29452728 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92971618 |
17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.77031399 |
18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70983239 |
19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69992529 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57949612 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56748915 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55973244 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54426235 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53298316 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52995727 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.50673688 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48427238 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48080691 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44513935 |
30 | Pertussis_Homo sapiens_hsa05133 | 1.36639530 |
31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35675383 |
32 | Tuberculosis_Homo sapiens_hsa05152 | 1.32885305 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29292206 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26950647 |
35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26531675 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.25680733 |
37 | Malaria_Homo sapiens_hsa05144 | 1.24335352 |
38 | Influenza A_Homo sapiens_hsa05164 | 1.22209484 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.21715521 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19599842 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19458730 |
42 | Apoptosis_Homo sapiens_hsa04210 | 1.15690771 |
43 | Platelet activation_Homo sapiens_hsa04611 | 1.06039899 |
44 | Salmonella infection_Homo sapiens_hsa05132 | 1.05737303 |
45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03476174 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94526563 |
47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93659080 |
48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91691096 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90804916 |
50 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84104890 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84103501 |
52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83428741 |
53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81883856 |
54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81881109 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81374384 |
56 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77532510 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71383343 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70914253 |
59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70221762 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69279590 |
61 | Hepatitis C_Homo sapiens_hsa05160 | 0.68775420 |
62 | DNA replication_Homo sapiens_hsa03030 | 0.68395574 |
63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64913775 |
64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60773148 |
65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59630644 |
66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58776793 |
67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57502814 |
68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56708618 |
69 | Base excision repair_Homo sapiens_hsa03410 | 0.54595444 |
70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53527488 |
71 | Lysosome_Homo sapiens_hsa04142 | 0.51991528 |
72 | Ribosome_Homo sapiens_hsa03010 | 0.47959776 |
73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47408384 |
74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46819990 |
75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46008867 |
76 | Spliceosome_Homo sapiens_hsa03040 | 0.45609417 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45586013 |
78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45257033 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45190301 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43852687 |
81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43582443 |
82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42407867 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41514960 |
84 | Endocytosis_Homo sapiens_hsa04144 | 0.40325447 |
85 | Mismatch repair_Homo sapiens_hsa03430 | 0.39880492 |
86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38131221 |
87 | Phagosome_Homo sapiens_hsa04145 | 0.36789486 |
88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36703735 |
89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34114184 |
90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32845490 |
91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32794752 |
92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31135757 |
93 | Amoebiasis_Homo sapiens_hsa05146 | 0.30219633 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29834236 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29765317 |
96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29425216 |
97 | RNA degradation_Homo sapiens_hsa03018 | 0.28328228 |
98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27526298 |
99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27405522 |
100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26251594 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25626199 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25424362 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.25361758 |
104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24858916 |
105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24128567 |
106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23872544 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23402930 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22675283 |
109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21358165 |
110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21295049 |
111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18431310 |
112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18425037 |
113 | Prostate cancer_Homo sapiens_hsa05215 | 0.18254059 |
114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17986962 |
115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16702614 |
116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15399905 |
117 | Cell cycle_Homo sapiens_hsa04110 | 0.15378442 |